Canada’s First Robotic Assisted Totally Intracorporeal Orthotopic Ileal Neobladder

Authors

  • Richard L. Haddad Fellow in Robotic Uro-Oncology, McGill University Health Centre Division of Urology, Montreal Quebec Canada
  • Patrick Richard Chief Resident in Urology, McGill University Health Centre Division of Urology, Montreal Quebec Canada
  • Franck Bladou Professor, Divisions of Urology and Oncology, McGill University Health Centre and Chief of Urology, Jewish General Hospital of Montreal and Director of Uro-Oncology, Segal Cancer Centre Jewish General Hospital of Montreal

DOI:

https://doi.org/10.5489/cuaj.417

Keywords:

robotics, urinary diversion, neobladder, orthotopic bladder substitute, intracorporeal, bladder cancer, laparoscopy

Abstract

Despite robotic-assisted radical cysto-prostatectomy being performed in several centres, the urinary diversion is most often performed extra-corporeal. A robotic intra-corporeal ileal neobladder is technically demanding and long-term functional outcome data is lacking. We performed a robotic intra-corporeal ileal neobladder in a 73-year-old man for muscle invasive non-metastatic bladder cancer. The total operative time was 6 hours 8 minutes. The estimated blood loss was 900 mL. There were no complications and he was discharged on day 12. The principles of open neobladder surgery were maintained, however key modifications were used to reduce technical difficulty and enable timely completion. We found that robotic intracorporeal ileal neobladder can be safely performed with an experienced robotic unit.

Downloads

Download data is not yet available.

Downloads

Published

2013-08-19

How to Cite

Haddad, R. L., Richard, P., & Bladou, F. (2013). Canada’s First Robotic Assisted Totally Intracorporeal Orthotopic Ileal Neobladder. Canadian Urological Association Journal, 7(7-8), e537–42. https://doi.org/10.5489/cuaj.417

Issue

Vol. 7 No. 7-8 (2013): CUAJ August

Section

Case Report

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.